News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • US equity futures and major European bourses were flat over the past hour.
  • Treasury yields traded near unchanged levels with minimal intraday movement.
  • Dollar hovered near prior-session levels against major currencies amid light news flow.
  • Brent and WTI crude prices were little changed on no fresh supply or demand news.
  • No significant economic releases, corporate earnings, or central-bank comments were published in the hour.
  • No major geopolitical events reported, leaving market risk sentiment unchanged.

Latest Articles

Capitol Federal: A Practical Income Trade with Modest Upside

Capitol Federal: A Practical Income Trade with Modest Upside

Capitol Federal Financial (CFFN) is not the flashiest bank stock, but its combination of a >4% dividend yield, single-digit price-to-book, and steady cash generation makes it a pragmatic trade for income-minded traders. We outline a mid-term long trade with an entry at $8.60, a stop at $7.40 and a target of $10.25 tied to valuation re-rating and ne…

First Community Bankshares, Inc. Announces Record Second Quarter 2026 Results and Quarterly Cash Dividend

First Community Bankshares, Inc. Announces Record Second Quarter 2026 Results and Quarterly Cash Dividend

First Community Bankshares, Inc. reported a record net income of $22.51 million for Q2 2026, an 83.84% increase from Q2 2025. The company also increased its quarterly dividend to $0.33 per share, marking the 41st consecutive year of regular dividends. Key performance highlights include strong net interest margin, improved loan portfolio growth post…

Superior Group of Companies to Announce Second Quarter 2026 Results

Superior Group of Companies to Announce Second Quarter 2026 Results

Superior Group of Companies, Inc. announced it will release its second quarter 2026 financial results on August 4, 2026, before market open. The company will host a teleconference the same day featuring its CEO and CFO to discuss the results, accessible via webcast and phone. Superior Group operates in healthcare apparel, branded products, and cont…

Hanmi Reports 2026 Second Quarter Results

Hanmi Reports 2026 Second Quarter Results

Hanmi Financial Corporation reported a net income of $23.5 million ($0.79 per diluted share) for Q2 2026, a 4.2% increase from Q1. The company delivered solid earnings growth driven by increased net interest income and lower credit loss expense. Deposits grew 2.3% sequentially to $7.0 billion, with noninterest-bearing deposits rising 5.2%, highligh…

Orrstown Financial Services, Inc. Reports Second Quarter 2026 Results

Orrstown Financial Services, Inc. Reports Second Quarter 2026 Results

Orrstown Financial Services, Inc. reported Q2 2026 net income of $21.2 million, slightly down from $21.8 million in Q1 2026, with a diluted EPS of $1.09. The company saw a 5% annualized increase in total loans, improved asset quality with reductions in classified and nonaccrual loans, and maintained strong capital ratios. The net interest margin wa…

Publication in Cancer Research Details Atebimetinib’s Broad, Durable Preclinical Activity and Favorable Tolerability Across RAS- and RAF-Mutant Tumors via Deep Cyclic Inhibition

Publication in Cancer Research Details Atebimetinib’s Broad, Durable Preclinical Activity and Favorable Tolerability Across RAS- and RAF-Mutant Tumors via Deep Cyclic Inhibition

Immuneering Corporation announced new preclinical data published in Cancer Research demonstrating its investigational drug atebimetinib exhibits broad and durable antitumor activity across KRAS-, NRAS-, and BRAF-mutant cancers by overcoming previous limitations of MEK inhibitors. The drug showed superior tumor inhibition and better tolerability com…

Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026

Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026

Tactile Systems Technology, a Nasdaq-listed medical technology company, announced it will release its fiscal second quarter 2026 financial results after market close on August 10, 2026, followed by a management conference call to discuss the results. The company develops at-home therapies for chronic disorders such as lymphedema and chronic venous …

Nurix Therapeutics Announces HSR Clearance of Global Collaboration with Roche to Co-Develop and Co-Commercialize Potential Best-in-Class BTK Degrader Bexobrutideg Across Malignant Hematology, Immunology and Neurology

Nurix Therapeutics Announces HSR Clearance of Global Collaboration with Roche to Co-Develop and Co-Commercialize Potential Best-in-Class BTK Degrader Bexobrutideg Across Malignant Hematology, Immunology and Neurology

Nurix Therapeutics announced the completion of its global collaboration with Roche to co-develop and co-commercialize bexobrutideg, an investigational BTK degrader targeting malignant hematology, immunology, and neurology indications. Under the agreement, Nurix received $700 million upfront and may earn up to $2.3 billion including milestones. Deve…

Large FX option expiries concentrated in midweek DTCC data

Large FX option expiries concentrated in midweek DTCC data

Data from the Depository Trust & Clearing Corporation show sizable currency option expiries scheduled for Wednesday, July 22, concentrated in several major dollar pairs and AUD and NZD crosses. The report lists specific strike levels and notional amounts for each affected currency pair, and notes several pairs with no large expiries on that date.

Microsoft’s AI Pivot Is Misread: A Mid-Term Trade Opportunity

Microsoft’s AI Pivot Is Misread: A Mid-Term Trade Opportunity

Market headlines about Copilot adoption and a recent class-action lawsuit have masked Microsoft’s durable cloud economics and cash-generation. At roughly $3.0 trillion market cap and trading near $399, the stock prices in meaningful AI execution risk. For disciplined traders who want asymmetric risk-reward, a mid-term long against a conservative st…